Literature DB >> 25761324

Use of a haemostatic matrix does not reduce blood loss in minimally invasive total knee arthroplasty.

Pierre-Emmanuel Schwab1, Emmanuel Thienpont1.   

Abstract

BACKGROUND: Blood loss can increase morbidity and the risk of transfusion after total knee arthroplasty (TKA). This study evaluated the difference in blood loss between minimally invasive TKA performed with and without intra-articular use of a haemostatic matrix (Floseal®).
MATERIALS AND METHODS: We retrospectively compared matched pairs in two groups (76 patients in each group): one group received conventional haemostasis (with bovie electrocoagulation), the other group was treated with an intra-articular haemostatic matrix (HM) as an adjunct to electrocoagulation. The outcomes compared were haemoglobin (Hb) and haematocrit levels at days 2 and 4 after surgery as a surrogate for blood loss, transfusion rate, surgical time, preoperative and postoperative range of motion (ROM) at days 21 and 42 and length of stay (LOS) in hospital.
RESULTS: No differences were observed for Hb levels at day 2 or day 4 between men in the two groups. In women, however, the mean Hb at day 2 was 11.1 g/dL (SD 1.3) for TKA with HM and 12.0 g/dL (SD 0.9) for TKA without HM (p<0.001), while that at day 4 was 10.6 g/dL (SD 1.3) for TKA with HM and 11.4 g/dL (SD 1.2) for TKA without HM (p<0.001). The haematocrit was higher for TKA without HM at day 2 (p=0.001) and day 4 (p=0.008). The transfusion rate for TKA with HM was 2.6% and for TKA without HM 0% (p=0.497), while the mean surgical time was 93 minutes (SD 12) vs 87 minutes (SD 14), respectively (p=0.0055). There were no differences in preoperative or postoperative ROM at days 21 and 42 between the two groups. The LOS was longer for TKA with HM than for TKA without HM (4.5 days and 4 days, respectively, p=0.011) influenced by the longer stay for the transfused patients. DISCUSSION: The present study showed that the use of Floseal had no effect on reducing either visible or hidden blood loss after TKA, as assessed by a drop in Hb or haematocrit and that hidden blood loss was more important in women treated with the HM.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25761324      PMCID: PMC4614296          DOI: 10.2450/2015.0199-14

Source DB:  PubMed          Journal:  Blood Transfus        ISSN: 1723-2007            Impact factor:   3.443


  29 in total

1.  Postoperative pain significantly influences postoperative blood loss in patients undergoing total knee replacement.

Authors:  Joanne Guay
Journal:  Pain Med       Date:  2006 Nov-Dec       Impact factor: 3.750

2.  An evaluation of the use of topical tranexamic acid in total knee arthroplasty.

Authors:  George F Chimento; Tamara Huff; J Lockwood Ochsner; Mark Meyer; Luci Brandner; Sheena Babin
Journal:  J Arthroplasty       Date:  2013-09       Impact factor: 4.757

Review 3.  Pain after knee arthroplasty: an unresolved issue.

Authors:  Irina Grosu; Patricia Lavand'homme; Emmanuel Thienpont
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-11-08       Impact factor: 4.342

Review 4.  A comparison of regional and general anaesthesia for total replacement of the hip or knee: a meta-analysis.

Authors:  S Hu; Z-Y Zhang; Y-Q Hua; J Li; Z-D Cai
Journal:  J Bone Joint Surg Br       Date:  2009-07

Review 5.  Preoperative blood management strategies for total knee arthroplasty.

Authors:  Bhaveen H Kapadia; Samik Banerjee; Kimona Issa; Mark J McElroy; Steven F Harwin; Michael A Mont
Journal:  J Knee Surg       Date:  2013-10-11       Impact factor: 2.757

6.  Platelet-rich plasma does not reduce blood loss or pain or improve range of motion after TKA.

Authors:  Timothy M Diiorio; Justin D Burkholder; Robert P Good; Javad Parvizi; Peter F Sharkey
Journal:  Clin Orthop Relat Res       Date:  2012-01       Impact factor: 4.176

7.  Blood loss in patients for total knee arthroplasty.

Authors:  Hiroshi Fujimoto; Toshifumi Ozaki; Kohji Asaumi; Hisayoshi Kato; Keichiro Nishida; Yasuhiro Takahara; Nobuhiro Abe; Hajime Inoue
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2003-02-19       Impact factor: 4.342

8.  Control of bleeding in endoscopic sinus surgery: use of a novel gelatin-based hemostatic agent.

Authors:  Richard M Gall; Ian J Witterick; Narinder S Shargill; Michael Hawke
Journal:  J Otolaryngol       Date:  2002-10

Review 9.  Use of FloSeal hemostatic sealant in transsphenoidal pituitary surgery: technical note.

Authors:  Dilantha B Ellegala; Nicholas F Maartens; Edward R Laws
Journal:  Neurosurgery       Date:  2002-08       Impact factor: 4.654

10.  Duration of postoperative fibrinolysis after total hip or knee replacement: a laboratory follow-up study.

Authors:  Antonia Blanié; Lorenn Bellamy; Yara Rhayem; Claire Flaujac; Charles Marc Samama; Michaela Fontenay; Nadia Rosencher
Journal:  Thromb Res       Date:  2012-11-26       Impact factor: 3.944

View more
  4 in total

1.  Preoperative haemoglobin cut-off values for the prediction of post-operative transfusion in total knee arthroplasty.

Authors:  Jared Ze Yang Yeh; Jerry Yongqiang Chen; Hamid Rahmatullah Bin Abd Razak; Bryan Huai Gu Loh; Ying Hao; Andy Khye Soon Yew; Shi-Lu Chia; Ngai Nung Lo; Seng Jin Yeo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-05-28       Impact factor: 4.342

2.  Use of a haemostatic matrix (Floseal®) does not reduce blood loss in minimally invasive total knee arthroplasty performed under continued aspirin.

Authors:  Pierre-Emmanuel Schwab; Emmanuel Thienpont
Journal:  Blood Transfus       Date:  2015-05-29       Impact factor: 3.443

3.  Use of patient-specific cutting blocks reduces blood loss after total knee arthroplasty.

Authors:  Vicente J León; María A Lengua; Víctor Calvo; Alonso J Lisón
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-12-20

4.  Comparison of Effects of a Thrombin-Based Hemostatic Agent and Topical Tranexamic Acid on Blood Loss in Patients with Preexisting Thromboembolic Risk Undergoing a Minimally Invasive Total Knee Arthroplasty. A Prospective Randomized Controlled Trial.

Authors:  Shih-Hsiang Yen; Po-Chun Lin; Cheng-Ta Wu; Jun-Wen Wang
Journal:  Biomed Res Int       Date:  2021-01-14       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.